Menta Capital’s Antares Pharma, Inc. ATRS Stock Holding History

Menta Capital’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-34,970	Closed	-$95K	–	657
2018 Q4	$95K	Sell	34,970 -22,461	-39%	-$74K	0.04%	504
2018 Q3	$193K	Buy	+57,431	New	+$177K	0.07%	489
2017 Q4	–	Sell	-91,482	Closed	-$296K	–	866
2017 Q3	$296K	Sell	91,482 -718	-0.8%	-$2.21K	0.04%	616
2017 Q2	$297K	Buy	+92,200	New	+$261K	0.04%	652
2015 Q1	–	Sell	-154,780	Closed	-$398K	–	841
2014 Q4	$398K	Buy	+154,780	New	+$348K	0.06%	483

Other funds holding ATRS

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Menta Capital's ATRS Position: Q1 2019 in Review

Menta Capital sold out of Antares Pharma, Inc. (ATRS) in Q1 2019, closing a stake of 34,970 shares — an estimated $95K sold.

Menta Capital first reported a position in ATRS in Q4 2014 and held it in 5 quarters. The position peaked at $398K in Q4 2014. 132 funds tracked by Wall St. Rank hold ATRS as of Q1 2019.

Menta Capital reported no remaining Antares Pharma, Inc. position as of Q1 2019 after selling out during the quarter.
Menta Capital sold 34,970 Antares Pharma, Inc. shares in Q1 2019, an estimated $95K.
Menta Capital first reported a position in Antares Pharma, Inc. in Q4 2014 and held it in 5 quarters.
Menta Capital's Antares Pharma, Inc. position peaked at $398K in Q4 2014.
132 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2019.

Based on Menta Capital's 13F filing for Q1 2019, filed 1 May 2019.